Sotac Pharma.
Craft Emerging Markets acquired 861,600 shares of Sotac Pharma in an open market transaction on March 13, 2026. This purchase increased their stake from 0.00% to 7.79%, crossing the 5% disclosure threshold.
A pharmaceutical manufacturer operating in India, Sotac Pharma produces and distributes a comprehensive range of pharmaceutical products across multiple therapeutic categories and treatment areas. Founded in 2015, the company engages in formulation development, active pharmaceutical ingredient sourcing, manufacturing operations, and distribution of medicines. It serves both domestic Indian markets and international customers through its established supply chains and regulatory compliance frameworks.
Focused on emerging market equities including India.